Reply

Clin Gastroenterol Hepatol. 2016 May;14(5):776-7. doi: 10.1016/j.cgh.2016.02.002. Epub 2016 Feb 4.

Authors

Emanuelle Bellaguarda¹, Atsushi Sakuraba²

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Section of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, Illinois.

PMID: 26853161
DOI: 10.1016/j.cgh.2016.02.002

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Viral / blood*
Crohn Disease / complications*
Crohn Disease / drug therapy*
Female
Humans
Immunosuppressive Agents / therapeutic use*
JC Virus / immunology*
Leukoencephalopathy, Progressive Multifocal / epidemiology*
Male
Natalizumab / therapeutic use*

Substances

Antibodies, Viral
Immunosuppressive Agents
Natalizumab